Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Androgen receptor status predicts development of brain metastases in ovarian cancers.
Mittica G, Senetta R, Scotto G, Aglietta M, Maggiorotto F, Ghisoni E, Genta S, Boldorini R, Manini C, Morra I, Buosi R, Sapino A, Cassoni P, Valabrega G. Mittica G, et al. Among authors: maggiorotto f. Oncotarget. 2017 Jun 20;8(25):41143-41153. doi: 10.18632/oncotarget.17068. Oncotarget. 2017. PMID: 28467804 Free PMC article.
A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience.
Ghisoni E, Katsaros D, Maggiorotto F, Aglietta M, Vaira M, De Simone M, Mittica G, Giannone G, Robella M, Genta S, Lucchino F, Marocco F, Borella F, Valabrega G, Ponzone R. Ghisoni E, et al. Among authors: maggiorotto f. J Ovarian Res. 2018 May 30;11(1):42. doi: 10.1186/s13048-018-0415-y. J Ovarian Res. 2018. PMID: 29843747 Free PMC article.
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers.
Mittica G, Goia M, Gambino A, Scotto G, Fonte M, Senetta R, Aglietta M, Borella F, Sapino A, Katsaros D, Maggiorotto F, Ghisoni E, Giannone G, Tuninetti V, Genta S, Eusebi C, Momi M, Cassoni P, Valabrega G. Mittica G, et al. Among authors: maggiorotto f. J Ovarian Res. 2020 May 4;13(1):53. doi: 10.1186/s13048-020-00655-2. J Ovarian Res. 2020. PMID: 32366278 Free PMC article.
TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin: TOP2A as marker of response to PLD in ovarian cancer.
Erriquez J, Becco P, Olivero M, Ponzone R, Maggiorotto F, Ferrero A, Scalzo MS, Canuto EM, Sapino A, Verdun di Cantogno L, Bruna P, Aglietta M, Di Renzo MF, Valabrega G. Erriquez J, et al. Among authors: maggiorotto f. Gynecol Oncol. 2015 Sep;138(3):627-33. doi: 10.1016/j.ygyno.2015.06.025. Epub 2015 Jun 20. Gynecol Oncol. 2015. PMID: 26100858
Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21).
Artioli G, Giannone G, Valabrega G, Maggiorotto F, Genta S, Pignata S, Lorusso D, Cormio G, Scalone S, Nicoletto MO, Greco F, Rossi E, Spagnoletti I, De Giorgi U, Orditura M, Mosconi AM, Kardhashi A, Bogliolo S, Borgato L. Artioli G, et al. Among authors: maggiorotto f. Gynecol Oncol. 2021 Jun;161(3):755-761. doi: 10.1016/j.ygyno.2021.04.014. Epub 2021 Apr 20. Gynecol Oncol. 2021. PMID: 33888336 Free article.
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience.
Tuninetti V, Di Napoli M, Ghisoni E, Maggiorotto F, Robella M, Scotto G, Giannone G, Turinetto M, Siatis D, Ponzone R, Vaira M, De Simone M, Scaffa C, Pignata S, Greggi S, Di Maio M, Valabrega G. Tuninetti V, et al. Among authors: maggiorotto f. Cancers (Basel). 2020 Aug 10;12(8):2239. doi: 10.3390/cancers12082239. Cancers (Basel). 2020. PMID: 32785193 Free PMC article.
Omission of axillary dissection after a positive sentinel node dissection may influence adjuvant chemotherapy indications in operable breast cancer patients.
Montemurro F, Maggiorotto F, Valabrega G, Kubatzki F, Rossi V, Magistris A, Marocco F, Gatti M, Sarotto I, Aglietta M, Ponzone R. Montemurro F, et al. Among authors: maggiorotto f. Ann Surg Oncol. 2012 Nov;19(12):3755-61. doi: 10.1245/s10434-012-2505-1. Epub 2012 Jul 18. Ann Surg Oncol. 2012. PMID: 22805871
Moderate immunohistochemical expression of HER-2 (2+) without HER-2 gene amplification is a negative prognostic factor in early breast cancer.
Rossi V, Sarotto I, Maggiorotto F, Berchialla P, Kubatzki F, Tomasi N, Redana S, Martinello R, Valabrega G, Aglietta M, Ponzone R, Montemurro F. Rossi V, et al. Among authors: maggiorotto f. Oncologist. 2012;17(11):1418-25. doi: 10.1634/theoncologist.2012-0194. Epub 2012 Sep 4. Oncologist. 2012. PMID: 22951668 Free PMC article.
44 results